Hca Healthcare, Inc. (HCA) intrinsic value & 10-year financials
Hca Healthcare, Inc. (HCA) has a Graham intrinsic value of $598.82 per share. At $458.84 on Oct 17, 2026, the stock trades 23% below that value. Over the last 10 fiscal years revenue grew 6.9% a year to $75.6B, with an average return on invested capital of -111.2%.
- Graham intrinsic value
- $598.82
- Share price (Oct 17, 2026)
- $458.84
- Price vs Graham value
- 23% below
- Market cap
- $109.9B
- Revenue (FY2025)
- $75.6B
- Revenue growth (10-yr CAGR)
- 6.9%
- ROIC (10-yr avg)
- -111.2%
- Free cash flow (FY2025)
- $7.7B
HCA 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $75.6B | $6.8B | $28.33 | $7.7B | — | 17.4% |
| FY2024 | $70.6B | $5.8B | $22.00 | $5.6B | — | 14.3% |
| FY2023 | $65.0B | $5.2B | $18.97 | $4.7B | — | 13.8% |
| FY2022 | $60.2B | $5.6B | $19.15 | $4.1B | — | 32.0% |
| FY2021 | $58.8B | $7.0B | $21.16 | $5.4B | — | -731.1% |
| FY2020 | $51.5B | $3.8B | $10.93 | $6.4B | — | -232.5% |
| FY2019 | $51.3B | $3.5B | $10.07 | $3.4B | — | -91.7% |
| FY2018 | $46.7B | $3.8B | $10.66 | $3.2B | — | -64.2% |
| FY2017 | $43.6B | $2.2B | $5.95 | $2.4B | — | -31.0% |
| FY2016 | $41.5B | $2.9B | $7.30 | $2.9B | — | -39.3% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
HCA Healthcare has demonstrated mature, steady growth, with revenue compounding at 6.9% annually over the past decade.
HCA Healthcare has historically struggled to out-earn its cost of capital, averaging just -15.8% ROIC.
Over the decade, HCA Healthcare shows that management has aggressively returned capital to shareholders by retiring 39.5% of outstanding shares, and that the company has leveraged its balance sheet to sustain operations.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, HCA Healthcare is modeled at 8.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $598.82 per share.